Globus Medical Inc (GMED)
74.88
+1.34
(+1.82%)
USD |
NYSE |
Nov 01, 16:00
74.87
-0.01
(-0.01%)
After-Hours: 20:00
Globus Medical Enterprise Value: 10.08B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 10.08B |
| October 31, 2024 | 9.895B |
| October 30, 2024 | 10.10B |
| October 29, 2024 | 9.997B |
| October 28, 2024 | 9.985B |
| October 25, 2024 | 9.845B |
| October 24, 2024 | 9.909B |
| October 23, 2024 | 9.943B |
| October 22, 2024 | 9.867B |
| October 21, 2024 | 9.889B |
| October 18, 2024 | 9.802B |
| October 17, 2024 | 9.947B |
| October 16, 2024 | 10.08B |
| October 15, 2024 | 9.964B |
| October 14, 2024 | 9.577B |
| October 11, 2024 | 9.493B |
| October 10, 2024 | 9.388B |
| October 09, 2024 | 9.476B |
| October 08, 2024 | 9.424B |
| October 07, 2024 | 9.403B |
| October 04, 2024 | 9.505B |
| October 03, 2024 | 9.421B |
| October 02, 2024 | 9.413B |
| October 01, 2024 | 9.470B |
| September 30, 2024 | 9.625B |
| Date | Value |
|---|---|
| September 27, 2024 | 9.499B |
| September 26, 2024 | 9.486B |
| September 25, 2024 | 9.463B |
| September 24, 2024 | 9.550B |
| September 23, 2024 | 9.581B |
| September 20, 2024 | 9.503B |
| September 19, 2024 | 9.497B |
| September 18, 2024 | 9.361B |
| September 17, 2024 | 9.327B |
| September 16, 2024 | 9.412B |
| September 13, 2024 | 9.382B |
| September 12, 2024 | 9.424B |
| September 11, 2024 | 9.317B |
| September 10, 2024 | 9.332B |
| September 09, 2024 | 9.419B |
| September 06, 2024 | 9.415B |
| September 05, 2024 | 9.524B |
| September 04, 2024 | 9.466B |
| September 03, 2024 | 9.711B |
| August 30, 2024 | 9.782B |
| August 29, 2024 | 9.699B |
| August 28, 2024 | 9.600B |
| August 27, 2024 | 9.650B |
| August 26, 2024 | 9.671B |
| August 23, 2024 | 9.694B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.189B
Minimum
Mar 16 2020
10.10B
Maximum
Oct 30 2024
6.319B
Average
6.227B
Median
Apr 08 2021
Enterprise Value Benchmarks
| Stryker Corp | 150.76B |
| Abbott Laboratories | 213.13B |
| Alphatec Holdings Inc | 1.596B |
| Orthofix Medical Inc | 739.08M |
| Insulet Corp | 17.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 31.76M |
| Revenue (Quarterly) | 629.69M |
| Total Expenses (Quarterly) | 565.57M |
| EPS Diluted (Quarterly) | 0.23 |
| Gross Profit Margin (Quarterly) | 58.70% |
| Profit Margin (Quarterly) | 5.04% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 1.71% |
| Normalized Earnings Yield | 1.272 |